Skip to main content

Table 1 Number of patients in the cohorts included in this study

From: A robust prognostic gene expression signature for early stage lung adenocarcinoma

   Includeda   
Cohort Available Stage I Stage II Total
Lee et al. 2008 [4] 138 39 12 51
Zhu et al. 2010 [5] 133 20 12 32
Shedden et al. 2008 [6] 505 164 43 207
Rousseaux et al. 2013 [7] 307 81 3 84
Okayama et al. 2012 [8] 246 162 42 204
Botling et al. 2013 [9] 196 31 4 35
Der et al. 2014 [10] 181 92 35 127
  1. apassed inclusion criteria: adenocarcinoma, no chemotherapy